FDA approves new drug for rare disease helping Overland Park family

On 2026-04-07, the U.S. Food and Drug Administration gave accelerated approval to a new drug for Hunter syndrome, a rare disease affecting fewer than 500 people in the United States. The approval concerned AVLAYAH, an enzyme drug therapy reported to be helping patients in treatment, including an Overland Park family featured in the story.